ResearcherUniversity of CopenhagenActive in the last 2 years
Renata Ialchina
Matched on ORCID iD 0000-0002-9508-853X; OpenAlex author ID A5072652936. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 33
2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 6
- Microenvironmental acidosis drives PARP- and ATM inhibitor resistance in p53 deficient pancreatic cancer. Co-author DOI 10.1016/j.isci.2026.115112↗
- pH-Dependent Microenvironmental Ionic Signaling in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1111/apha.70183↗
- Tumor microenvironment acidosis favors pancreatic cancer stem cell properties and in vivo metastasis. Co-author DOI 10.1016/j.isci.2025.111956↗
- Adaptation to an acid microenvironment promotes pancreatic cancer organoid growth and drug resistance. First author DOI 10.1016/j.celrep.2024.114409↗
- Crosstalk between tumor acidosis, p53 and extracellular matrix regulates pancreatic cancer aggressiveness. First author DOI 10.1002/ijc.34367↗
- Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targets. First author DOI 10.1007/s10555-021-10004-4↗
Closest collaborators
The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stine F. Pedersen · 6 shared papers, 2021–2026 · strength 1.24
- Paper Microenvironmental acidosis drives PARP- and ATM inhibitor resistance in p53 deficient pancreatic cancer. DOI 10.1016/j.isci.2026.115112↗
- Paper Tumor microenvironment acidosis favors pancreatic cancer stem cell properties and in vivo metastasis. DOI 10.1016/j.isci.2025.111956↗
- Paper Adaptation to an acid microenvironment promotes pancreatic cancer organoid growth and drug resistance. DOI 10.1016/j.celrep.2024.114409↗
- Albin Sandelin · 5 shared papers, 2023–2026 · strength 1.05
- Paper Microenvironmental acidosis drives PARP- and ATM inhibitor resistance in p53 deficient pancreatic cancer. DOI 10.1016/j.isci.2026.115112↗
- Paper Tumor microenvironment acidosis favors pancreatic cancer stem cell properties and in vivo metastasis. DOI 10.1016/j.isci.2025.111956↗
- Paper Adaptation to an acid microenvironment promotes pancreatic cancer organoid growth and drug resistance. DOI 10.1016/j.celrep.2024.114409↗
- Dominika Czaplińska · 4 shared papers, 2021–2026 · strength 0.83
- Paper Microenvironmental acidosis drives PARP- and ATM inhibitor resistance in p53 deficient pancreatic cancer. DOI 10.1016/j.isci.2026.115112↗
- Paper Adaptation to an acid microenvironment promotes pancreatic cancer organoid growth and drug resistance. DOI 10.1016/j.celrep.2024.114409↗
- Paper Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targe… DOI 10.1007/s10555-021-10004-4↗
- Henriette Berg Andersen · 4 shared papers, 2021–2026 · strength 0.83
- Paper Microenvironmental acidosis drives PARP- and ATM inhibitor resistance in p53 deficient pancreatic cancer. DOI 10.1016/j.isci.2026.115112↗
- Paper Adaptation to an acid microenvironment promotes pancreatic cancer organoid growth and drug resistance. DOI 10.1016/j.celrep.2024.114409↗
- Paper Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targe… DOI 10.1007/s10555-021-10004-4↗
- Arnaud Stigliani · 3 shared papers, 2023–2026 · strength 0.64
- Paper Microenvironmental acidosis drives PARP- and ATM inhibitor resistance in p53 deficient pancreatic cancer. DOI 10.1016/j.isci.2026.115112↗
- Paper Adaptation to an acid microenvironment promotes pancreatic cancer organoid growth and drug resistance. DOI 10.1016/j.celrep.2024.114409↗
- Paper Crosstalk between tumor acidosis, p53 and extracellular matrix regulates pancreatic cancer aggressiveness. DOI 10.1002/ijc.34367↗
- Luis A. Pardo · 2 shared papers, 2026 · strength 0.47
- Mette Flinck · 2 shared papers, 2023–2025 · strength 0.37
- Frauke Alves · 2 shared papers, 2023–2026 · strength 0.34
- Michala G. Rolver · 1 shared paper, 2025 · strength 0.22
- Luís Arnes · 1 shared paper, 2025 · strength 0.22
- Pawel Swietach · 1 shared paper, 2026 · strength 0.19
- Sofie Hagelund · 1 shared paper, 2026 · strength 0.19
- Verena Hofschröer · 1 shared paper, 2026 · strength 0.19
- Laura Mezzanotte · 1 shared paper, 2026 · strength 0.19
- Zoltán Pethő · 1 shared paper, 2026 · strength 0.19
- Tiago M. A. Carvalho · 1 shared paper, 2026 · strength 0.19
- Stephan J. Reshkin · 1 shared paper, 2026 · strength 0.19
- Torsten Hechler · 1 shared paper, 2026 · strength 0.19
- Rosa Angela Cardone · 1 shared paper, 2026 · strength 0.19
- Julie Schnipper · 1 shared paper, 2026 · strength 0.19
- Wiktoria Błaszczak · 1 shared paper, 2026 · strength 0.19
- Ganga Deshar · 1 shared paper, 2026 · strength 0.19
- Ivana Novak · 1 shared paper, 2026 · strength 0.19
- Albrecht Schwab · 1 shared paper, 2026 · strength 0.19
- Natalia B. Prevarskaya · 1 shared paper, 2026 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.